Sales and Marketing

Showing 15 posts of 11526 posts found.

Early access to experimental drugs for terminally ill

March 25, 2008 Sales and Marketing

Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …

Latest news from Datamonitor

March 20, 2008 Sales and Marketing

With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …

Nexium and Seroquel face US generic fight

March 20, 2008 Sales and Marketing

AstraZeneca is to face a crucial court battle over one of its biggest brands, Seroquel. Generics companies Teva and Sandoz …

Industry doubts government commitment to innovation

March 19, 2008 Sales and Marketing

The government has unveiled high plans to make the UK a world leader in innovation, but the pharmaceutical industry remains …

Celgene buys up Pharmion

March 14, 2008 Sales and Marketing

Specialist biopharma company Celgene has bought Pharmion for $2.9 billion in a bid to become a global leader in haematology …

Why should we listen to you?

March 12, 2008 Medical Communications, Sales and Marketing industry relations, marketing, stakeholders

Last month, Pharmafocus showed how market access can be a platform to build a cohesive strategy that brings together sales, …

Latest news from Datamonitor

March 12, 2008 Sales and Marketing

Type 2 diabetes driving epidemic Type 2 diabetes poses one of the greatest public health threats of the 21st century. …

Abbott to work on Tarceva diagnostic

March 12, 2008 Sales and Marketing

Abbott is to develop a diagnostic test for Tarceva to identify patients who could most benefit from the lung cancer …

New laws will oblige pharma to release data

March 7, 2008 Sales and Marketing

The UK government has pledged to introduce new legislation that will require pharmaceutical companies to disclose all data from clinical …

Efexor successor approved in US

March 7, 2008 Sales and Marketing

Wyeth's Pristiq, a refined version of its top-selling depression treatment Efexor, has been approved in the US. Pristiq (desvenlafaxine) delivers …

Renovo wounded by cosmetic drug setback

March 7, 2008 Research and Development, Sales and Marketing

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …

NICE’s approach to benefits and costs to be reviewed

March 7, 2008 Sales and Marketing

The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …

Diabetes nurses would cut emergency admissions

March 7, 2008 Sales and Marketing

Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …

Latest news from Datamonitor

March 5, 2008 Sales and Marketing

APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …
The Gateway to Local Adoption Series

Latest content